| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, and Atlanta Veterans Affairs Medical Center, Decatur, Georgia.
Correspondence to Dr. Harold A. Franch, Renal Division, Emory University School of Medicine, W.M.B., Room 338, 1639 Pierce Drive, N.E., Atlanta, GA 30322. Phone: 404-727-9217; Fax: 404-727-3425; E-mail: hfranch{at}emory.edu
Abstract. Epidermal growth factor (EGF) causes proliferation in renal tubular cells but, when it is combined with transforming growth factor-ß1, it causes hypertrophy by a mechanism that requires the activity of the retinoblastoma family of proteins. In contrast, ammonia causes hypertrophy by decreasing lysosomal proteolysis; in some cell types, it also decreases cellular proliferation. These studies were designed to determine whether ammonia, like transforming growth factor-ß1, could convert EGF-induced hyperplasia to hypertrophy. Cultured NRK-52E cells were incubated with EGF and/or ammonia and the protein/DNA ratio was measured, as a marker of hypertrophy. Addition of ammonia to EGF-treated NRK-52E cells converted EGF-induced hyperplasia to hypertrophy, because of a decrease in DNA synthesis. The mechanism involved no change in EGF-induced protein synthesis. Inhibition of lysosomal function with a proton pump inhibitor or lysosomal protease inhibitors also converted the response of EGF-treated cells to hypertrophy. Expression of the human papilloma virus 16 E7 protein (which inactivates all members of the retinoblastoma family) prevented ammonia from converting EGF-induced hyperplasia to hypertrophy. It is concluded that ammonia converts EGF-induced hyperplasia to hypertrophy by a mechanism that involves suppression of lysosomal function and this response can be blocked by inhibiting the activity of the retinoblastoma family of proteins.
This article has been cited by other articles:
![]() |
W. Shen, N. S. Brown, P. F. Finn, J. F. Dice, and H. A. Franch Akt and Mammalian Target of Rapamycin Regulate Separate Systems of Proteolysis in Renal Tubular Cells J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2414 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Franch, S. Raissi, X. Wang, B. Zheng, J. L. Bailey, and S. R. Price Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: consequences on proteolysis Am J Physiol Renal Physiol, October 1, 2004; 287(4): F700 - F706. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cheval, J. P. Duong Van Huyen, P. Bruneval, J.-M. Verbavatz, J.-M. Elalouf, and A. Doucet Plasticity of mouse renal collecting duct in response to potassium depletion Physiol Genomics, September 16, 2004; 19(1): 61 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Franch, X. Wang, S. Sooparb, N. S. Brown, and J. Du Phosphatidylinositol 3-Kinase Activity Is Required for Epidermal Growth Factor to Suppress Proteolysis J. Am. Soc. Nephrol., April 1, 2002; 13(4): 903 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Franch, S. Sooparb, J. Du, and N. S. Brown A Mechanism Regulating Proteolysis of Specific Proteins during Renal Tubular Cell Growth J. Biol. Chem., May 25, 2001; 276(22): 19126 - 19131. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673